Practice parameters for the treatment of narcolepsy: An update for 2000

M. Littner, S. F. Johnson, William Vaughn McCall, W. McDowell Anderson, D. Davila, K. Hartse, C. A. Kushida, M. S. Wise, M. Hirshkowitz, B. T. Woodson

Research output: Contribution to journalArticlepeer-review

144 Scopus citations


Successful treatment of narcolepsy requires an accurate diagnosis to exclude patients with other sleep disorders, which have different treatments, and to avoid unnecessary complications of drug treatment. Treatment objectives should be tailored to individual circumstances. Modafinil, amphetamine, methamphetamine, dextroamphetamine, methylphenidate, selegiline, pemoline, tricyclic antidepressants, and fluoxetine are effective treatments for narcolepsy, but the quality of published clinical evidence supporting them varies. Scheduled naps can be beneficial to combat sleepiness, but naps seldom suffice as primary therapy. Regular follow up of patients with narcolepsy is necessary to educate patients and their families, monitor for complications of therapy and emergent of other sleep disorders, and help the patient adapt to the disease.

Original languageEnglish (US)
StatePublished - Jun 15 2001


Dive into the research topics of 'Practice parameters for the treatment of narcolepsy: An update for 2000'. Together they form a unique fingerprint.

Cite this